{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:23:51Z","timestamp":1775539431411,"version":"3.50.1"},"reference-count":227,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.mcna.2006.07.011","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:20Z","timestamp":1168439300000},"page":"1141-1163","source":"Crossref","is-referenced-by-count":28,"title":["Antimicrobial Therapy of Clostridium difficile-Associated Diarrhea"],"prefix":"10.1016","volume":"90","author":[{"given":"Emilio","family":"Bouza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Burillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1198-743x.2001.00289.x","article-title":"Epidemiology of Clostridium difficile-associated infections","volume":"7","author":"Barbut","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"10.1016\/j.mcna.2006.07.011_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-0691.2005.01165.x","article-title":"Clinical manifestations, treatment and control of infections caused by Clostridium difficile","volume":"11","author":"Bouza","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1473-3099(06)70366-8","article-title":"Clostridium difficile epidemic strain far reaching","volume":"6","author":"Quirk","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMc053654","article-title":"Epidemic Clostridium difficile","volume":"354","author":"Musher","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/500264","article-title":"Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning","volume":"42","author":"Beaulieu","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/502600","article-title":"Clostridium difficile: responding to a new threat from an old enemy","volume":"26","author":"McDonald","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","article-title":"A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use","volume":"26","author":"Muto","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"23","key":"10.1016\/j.mcna.2006.07.011_bib8","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMe058221","article-title":"The new Clostridium difficile\u2014what does it mean?","volume":"353","author":"Bartlett","year":"2005","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.mcna.2006.07.011_bib9","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.mcna.2006.07.011_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1086\/647687","article-title":"Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control","volume":"18","author":"Lai","year":"1997","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1086\/646934","article-title":"Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982\u20131991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0195-6701(95)90074-8","article-title":"Clostridium difficile-associated diarrhoea and length of hospital stay","volume":"31","author":"Macgowan","year":"1995","journal-title":"J Hosp Infect"},{"issue":"8947","key":"10.1016\/j.mcna.2006.07.011_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(95)90439-5","article-title":"Increased length of hospital stay due to Clostridium difficile associated diarrhoea","volume":"345","author":"Riley","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0195-6701(96)90122-X","article-title":"Financial burden of hospital-acquired Clostridium difficile infection","volume":"34","author":"Wilcox","year":"1996","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF02090164","article-title":"Clostridium difficile\u2014a common and costly colitis","volume":"34","author":"Kofsky","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.mcna.2006.07.011_bib16","series-title":"Bergey's manual of systematic bacteriology, vol. 2","first-page":"1141","article-title":"Genus Clostridium Prazmowski","author":"Cato","year":"1986"},{"issue":"Suppl C","key":"10.1016\/j.mcna.2006.07.011_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/41.suppl_3.29","article-title":"The diagnosis of Clostridium difficile-associated disease","volume":"41","author":"Brazier","year":"1998","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"10.1016\/j.mcna.2006.07.011_bib18","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1093\/nar\/18.13.4004","article-title":"Nucleotide sequence of Clostridium difficile toxin B gene","volume":"18","author":"Barroso","year":"1990","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/IAI.58.2.480-488.1990","article-title":"Molecular characterization of the Clostridium difficile toxin A gene","volume":"58","author":"Dove","year":"1990","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0882-4010(95)90263-5","article-title":"The toxigenic element of Clostridium difficile strain VPI 10463","volume":"19","author":"Hammond","year":"1995","journal-title":"Microb Pathog"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2006.07.011_bib21","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1093\/clinids\/12.Supplement_2.S185","article-title":"Virulence factors of Clostridium difficile","volume":"12","author":"Borriello","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/IAI.47.2.349-352.1985","article-title":"Effects of Clostridium difficile toxins given intragastrically to animals","volume":"47","author":"Lyerly","year":"1985","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib23","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/IAI.60.11.4633-4639.1992","article-title":"Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile","volume":"60","author":"Lyerly","year":"1992","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diagmicrobio.2004.12.015","article-title":"Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital","volume":"52","author":"Martirosian","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/MMBR.68.3.373-402.2004","article-title":"Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins","volume":"68","author":"Barth","year":"2004","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/427113","article-title":"A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes","volume":"40","author":"McEllistrem","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1099\/jmm.0.45804-0","article-title":"Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains","volume":"54","author":"Barbut","year":"2005","journal-title":"J Med Microbiol"},{"issue":"9","key":"10.1016\/j.mcna.2006.07.011_bib28","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1128\/JCM.42.9.4316-4318.2004","article-title":"Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary","volume":"42","author":"Terhes","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1128\/JCM.42.5.1933-1939.2004","article-title":"Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile","volume":"42","author":"Goncalves","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1099\/jmm.0.45809-0","article-title":"Toxigenic status of Clostridium difficile in a large Spanish teaching hospital","volume":"54","author":"Alonso","year":"2005","journal-title":"J Med Microbiol"},{"issue":"Pt 9","key":"10.1016\/j.mcna.2006.07.011_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.45610-0","article-title":"Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital","volume":"53","author":"Geric","year":"2004","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.mcna.2006.07.011_bib32","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/archinte.162.19.2177","article-title":"The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea","volume":"162","author":"Hurley","year":"2002","journal-title":"Arch Intern Med"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1099\/jmm.0.05376-0","article-title":"Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization","volume":"53","author":"Ozaki","year":"2004","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mcna.2006.07.011_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.med.49.1.375","article-title":"Clostridium difficile infection","volume":"49","author":"Kelly","year":"1998","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/dkg115","article-title":"Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy","volume":"51","author":"Gopal Rao","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/infdis\/169.1.127","article-title":"Epidemiology of community-acquired Clostridium difficile-associated diarrhea","volume":"169","author":"Hirschhorn","year":"1994","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib37","first-page":"287","article-title":"Community-acquired Clostridium difficile infection","volume":"36","author":"Kyne","year":"1998","journal-title":"J\u00a0Infect"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2006.07.011_bib38","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1093\/clinids\/20.Supplement_2.S263","article-title":"Community-acquired Clostridium difficile-associated diarrhea","volume":"20","author":"Riley","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib39","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1016\/S0002-9270(00)02068-2","article-title":"Leukocytosis and Clostridium difficile-associated diarrhea","volume":"95","author":"Bartlett","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib40","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1111\/j.1572-0241.2000.03284.x","article-title":"Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea","volume":"95","author":"Bulusu","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib41","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.SMJ.0000054537.20978.D4","article-title":"Leukemoid reactions complicating colitis due to Clostridium difficile","volume":"97","author":"Marinella","year":"2004","journal-title":"South Med J"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1469-0691.2001.00313.x","article-title":"Extra-intestinal infections caused by Clostridium difficile","volume":"7","author":"Garcia-Lechuz","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.49.2.172","article-title":"Nosocomial empyema caused by Clostridium difficile","volume":"49","author":"Simpson","year":"1996","journal-title":"J\u00a0Clin Pathol"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib44","first-page":"337","article-title":"Extra-intestinal Clostridium difficile","volume":"4","author":"Watt","year":"1987","journal-title":"Microbiol Sci"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Clinical practice. Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib46","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/520276","article-title":"Clostridium difficile\u2013associated diarrhea","volume":"26","author":"Johnson","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib47","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/137.4.464","article-title":"Clindamycin-induced enterocolitis in hamsters","volume":"137","author":"Lusk","year":"1978","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.mcna.2006.07.011_bib48","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199911253412203","article-title":"Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals","volume":"341","author":"Johnson","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/381551","article-title":"Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use","volume":"38","author":"Gaynes","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib50","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1086\/382084","article-title":"Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem","volume":"38","author":"Gerding","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib51","first-page":"201","article-title":"Clinical manifestations and outcome of Pseudomembranous colitis in an elderly population in Israel","volume":"6","author":"Moshkowitz","year":"2004","journal-title":"Isr Med Assoc J"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/501997","article-title":"Clostridium difficile in long-term-care facilities for the elderly","volume":"23","author":"Simor","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib53","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1111\/j.1572-0241.1999.01534.x","article-title":"Clostridium difficile-associated diarrhea in the elderly","volume":"94","author":"Brandt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib54","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/clinids\/17.4.672","article-title":"Infection due to Clostridium difficile among elderly residents of a long-term-care facility","volume":"17","author":"Simor","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib55","first-page":"537","article-title":"Clostridium difficile infections in HIV-positive patients","volume":"31","author":"Wongwanich","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/mic.2000.107585","article-title":"HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations","volume":"28","author":"Anastasi","year":"2000","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib57","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00042560-199711010-00006","article-title":"Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors","volume":"16","author":"Barbut","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib58","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004836-199304000-00004","article-title":"Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment","volume":"16","author":"Cozart","year":"1993","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib59","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00126334-200212150-00013","article-title":"Clostridium difficile-associated diarrhea in patients with HIV: a 4-year survey","volume":"31","author":"Saddi","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/501987","article-title":"Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospital","volume":"23","author":"Pulvirenti","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0732-8893(02)00462-5","article-title":"Epidemiology and outcome of Clostridium difficile infection and diarrhea in HIV infected inpatients","volume":"44","author":"Pulvirenti","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib62","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pelaez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib63","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/517233","article-title":"Clostridium difficile-associated diarrhea in human immunodeficiency virus infection\u2014a changing scenario","volume":"28","author":"Tacconelli","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1034\/j.1399-0012.2002.01129.x","article-title":"Diarrhoea following renal transplantation","volume":"16","author":"Altiparmak","year":"2002","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1198-743x.2001.00315.x","article-title":"Clinical microbiological case: a heart transplant recipient with diarrhea and abdominal pain. Recurring C. difficile infection","volume":"7","author":"Munoz","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.bmt.1702086","article-title":"High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients","volume":"25","author":"Avery","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-0012.1999.130407.x","article-title":"Clostridium difficile colitis after kidney and kidney\u2013pancreas transplantation","volume":"13","author":"West","year":"1999","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1399-3062.2004.00040.x","article-title":"Clostridium difficile colitis in patients after kidney and pancreas\u2013kidney transplantation","volume":"6","author":"Keven","year":"2004","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.mcna.2006.07.011_bib69","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/clinids\/16.Supplement_4.S239","article-title":"Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile","volume":"16","author":"Mulligan","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib70","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N Engl J Med"},{"issue":"9103","key":"10.1016\/j.mcna.2006.07.011_bib71","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","article-title":"Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea","volume":"351","author":"Shim","year":"1998","journal-title":"Lancet"},{"issue":"9251","key":"10.1016\/j.mcna.2006.07.011_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/IAI.62.2.384-389.1994","article-title":"Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection","volume":"62","author":"Warny","year":"1994","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib74","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1128\/JCM.42.10.4863-4865.2004","article-title":"Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A\/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea","volume":"42","author":"Snell","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0732-8893(02)00413-3","article-title":"The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A\/B and cytotoxin assays","volume":"43","author":"Alfa","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib76","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/JCM.39.5.1996-1998.2001","article-title":"Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A + B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains","volume":"39","author":"Lozniewski","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib77","first-page":"739","article-title":"Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee","volume":"92","author":"Fekety","year":"1997","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib78","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/JCM.34.5.1161-1165.1996","article-title":"Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens","volume":"34","author":"Silletti","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib79","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01695667","article-title":"Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea","volume":"15","author":"Peterson","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib80","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjmed.2005.08.026","article-title":"Lack of value of repeat stool testing for Clostridium difficile toxin","volume":"119","author":"Mohan","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib81","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/JCM.43.6.2994-2995.2005","article-title":"Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin","volume":"43","author":"Borek","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"Suppl 22","key":"10.1016\/j.mcna.2006.07.011_bib82","first-page":"16","article-title":"Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture","author":"Thelestam","year":"1980","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.mcna.2006.07.011_bib83","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/infdis\/140.5.765","article-title":"Cytotoxicity assay in antibiotic-associated colitis","volume":"140","author":"Chang","year":"1979","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib84","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/infdis\/149.5.781","article-title":"Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens","volume":"149","author":"Laughon","year":"1984","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2006.07.011_bib85","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01709364","article-title":"Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea","volume":"15","author":"Jacobs","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib86","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-135-6-200109180-00012","article-title":"Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay","volume":"135","author":"Johnson","year":"2001","journal-title":"Ann Intern Med"},{"issue":"8686","key":"10.1016\/j.mcna.2006.07.011_bib87","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0140-6736(90)90267-9","article-title":"Rapid identification of toxigenic Clostridium difficile by polymerase chain reaction","volume":"335","author":"Wren","year":"1990","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib88","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1128\/JCM.36.8.2178-2182.1998","article-title":"Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR","volume":"36","author":"Kato","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1469-0691.1997.tb00271.x","article-title":"Rapid detection of toxigenic Clostridium difficile strains by a nested PCR of the toxin B gene","volume":"3","author":"Alonso","year":"1997","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib90","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0195-6701(99)90052-X","article-title":"Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene","volume":"41","author":"Alonso","year":"1999","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.mcna.2006.07.011_bib91","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","article-title":"Practise guidelines for the management of infectious diarrhea","volume":"32","author":"Guerrant","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib92","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/648363","article-title":"Clostridium difficile-associated diarrhea and colitis","volume":"16","author":"Gerding","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1099\/00222615-9-2-129","article-title":"Clostridium difficile: isolation and characteristics","volume":"9","author":"Hafiz","year":"1976","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib94","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/jcm.9.2.214-219.1979","article-title":"Selective and differential medium for isolation of Clostridium difficile","volume":"9","author":"George","year":"1979","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib95","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhin.2001.1000","article-title":"\u201cSecond-look\u201d cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD","volume":"48","author":"Bouza","year":"2001","journal-title":"J Hosp Infect"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1099\/jmm.0.45844-0","article-title":"Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture","volume":"54","author":"Delmee","year":"2005","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib97","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2214\/AJR.04.1697","article-title":"Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings","volume":"186","author":"Ash","year":"2006","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/107662904323047817","article-title":"Antimicrobial susceptibility of equine and environmental isolates of Clostridium difficile","volume":"10","author":"Baverud","year":"2004","journal-title":"Microb Drug Resist"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib99","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0924-8579(02)00180-2","article-title":"In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait","volume":"20","author":"Jamal","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib100","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1128\/AAC.46.4.1136-1140.2002","article-title":"Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections","volume":"46","author":"Goldstein","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib101","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jac\/47.4.467","article-title":"In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria","volume":"47","author":"Wexler","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib102","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/AAC.45.6.1860-1867.2001","article-title":"In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib103","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1128\/AAC.43.11.2607","article-title":"Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997","volume":"43","author":"Barbut","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib104","first-page":"383","article-title":"Studies on the resistance of Clostridium difficile to antimicrobial agents","volume":"267","author":"Wust","year":"1988","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [A]"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/AAC.27.4.674","article-title":"In vitro activity of cefbuperazone against anaerobic bacteria","volume":"27","author":"Wexler","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"issue":"6A","key":"10.1016\/j.mcna.2006.07.011_bib106","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(85)90098-1","article-title":"Review of the in vitro spectrum of activity of imipenem","volume":"78","author":"Jones","year":"1985","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib107","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1128\/AAC.47.11.3667-3671.2003","article-title":"In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria","volume":"47","author":"Liebetrau","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib108","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jac\/47.2.195","article-title":"In vitro activity of new quinolones against Clostridium difficile","volume":"47","author":"Alonso","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib109","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/oxfordjournals.jac.a002693","article-title":"In vitro activity of sitafloxacin against Clostridium difficile","volume":"47","author":"Ackermann","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/jac\/46.4.551","article-title":"In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates","volume":"46","author":"Wilcox","year":"2000","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/45.1.31","article-title":"Comparative in vitro activity of moxifloxacin against gram-positive clinical isolates","volume":"45","author":"Hoogkamp-Korstanje","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib112","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/45.4.437","article-title":"In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin","volume":"45","author":"Fung-Tomc","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.mcna.2006.07.011_bib113","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.43.9.2231","article-title":"In vitro activity of gemifloxacin (SB 265805) against anaerobes","volume":"43","author":"Goldstein","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib114","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.43.11.2726","article-title":"Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes","volume":"43","author":"Goldstein","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2006.07.011_bib115","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/clinids\/23.Supplement_1.S15","article-title":"In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria","volume":"23","author":"Nord","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib116","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-1135(03)00061-0","article-title":"Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs","volume":"94","author":"Marks","year":"2003","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib117","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000007297","article-title":"In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species","volume":"46","author":"Marchese","year":"2000","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib118","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1345\/aph.1E397","article-title":"Ramoplanin: a lipoglycodepsipeptide antibiotic","volume":"39","author":"Farver","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib119","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1128\/AAC.49.3.1157-1159.2005","article-title":"In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole","volume":"49","author":"Pelaez","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.47.1.337-341.2003","article-title":"In vitro activities of daptomycin, vancomycin, quinupristin\u2013dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates","volume":"47","author":"Goldstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib121","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1128\/AAC.32.5.788","article-title":"In vitro activities of daptomycin (LY146032) and paldimycin (U-70,138F) against anaerobic gram-positive bacteria","volume":"32","author":"Chow","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib122","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/AAC.48.6.2149-2152.2004","article-title":"In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp","volume":"48","author":"Goldstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib123","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/AAC.46.5.1617-1618.2002","article-title":"In vitro activity of linezolid against Clostridium difficile","volume":"46","author":"Pelaez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1179\/joc.2003.15.2.113","article-title":"Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria","volume":"15","author":"Phillips","year":"2003","journal-title":"J Chemother"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib125","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jac\/dkg113","article-title":"In vitro activity of linezolid against Clostridium difficile","volume":"51","author":"Ackermann","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.mcna.2006.07.011_bib126","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/AAC.44.9.2254-2258.2000","article-title":"In vitro and in vivo activities of nitazoxanide against Clostridium difficile","volume":"44","author":"McVay","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib127","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/AAC.40.10.2266","article-title":"In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms","volume":"40","author":"Dubreuil","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2006.07.011_bib128","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1086\/516235","article-title":"Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains","volume":"25","author":"Jang","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2006.07.011_bib129","unstructured":"Pel\u00e1ez T, Cercenado E, Alcal\u00e1 L, et\u00a0al. Heterogeneous resistance to metronidazole in Clostridium difficile isolates from patients with Clostridium difficile associated-diarrhoea. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington (DC): American Society for Microbiology; 2004."},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2307\/30145589","article-title":"Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982\u20131991","volume":"15","author":"Olson","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8358","key":"10.1016\/j.mcna.2006.07.011_bib131","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","article-title":"Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis","volume":"2","author":"Teasley","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib132","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.mcg.0000190761.80615.0f","article-title":"Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea","volume":"40","author":"Modena","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib133","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea","volume":"22","author":"Wenisch","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib134","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/506387","article-title":"New drugs for Clostridium difficile infection","volume":"43","author":"Bartlett","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib135","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/430317","article-title":"Metronidazole for Clostridium difficile-associated disease: is it okay for mom?","volume":"40","author":"Gerding","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib136","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.269.1.71","article-title":"Diagnosis and treatment of Clostridium difficile colitis","volume":"269","author":"Fekety","year":"1993","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004610.pub2","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhea in adults","author":"Bricker","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib138","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0016-5085(85)90206-9","article-title":"Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin","volume":"89","author":"Young","year":"1985","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib139","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archinte.146.6.1101","article-title":"Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial","volume":"146","author":"Dudley","year":"1986","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib140","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0016-5085(19)30520-7","article-title":"Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin","volume":"78","author":"Chang","year":"1980","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib141","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.36.10.2192","article-title":"Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea","volume":"36","author":"de Lalla","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.mcna.2006.07.011_bib142","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1128\/AAC.33.7.1125","article-title":"Treatment of Clostridium difficile-associated disease with teicoplanin","volume":"33","author":"de Lalla","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib143","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/jac\/dkh278","article-title":"A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea","volume":"54","author":"Wullt","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib144","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/340519","article-title":"Nitazoxanide as a broad-spectrum antiparasitic agent","volume":"185","author":"Arya","year":"2002","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2006.07.011_bib145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1185\/030079905X50534","article-title":"Use of nitazoxanide as a new therapeutic option for persistent diarrhea: a pediatric perspective","volume":"21","author":"Cohen","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib146","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","article-title":"Nitazoxanide for the treatment of Clostridium difficile colitis","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.mcna.2006.07.011_bib147","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(05)70215-2","article-title":"Treatment of Clostridium difficile-associated disease: old therapies and new strategies","volume":"5","author":"Aslam","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib148","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.35.6.1108","article-title":"In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile","volume":"35","author":"Swanson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mcna.2006.07.011_bib149","unstructured":"Louie T, Emery J, Krulicky W, et\u00a0al. PAR-101 is selectively efective against C. difficile in vivo and has minimal effect on the anaerobic fecal flora (Poster LB2\u201330). In: Microbiology ASf, editor. Proceedings of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy; Washington (DC): American Society for Microbiology; 2005."},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2006.07.011_bib150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081990","article-title":"Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential","volume":"51","author":"Scarpignato","year":"2005","journal-title":"Chemotherapy"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib151","first-page":"483","article-title":"In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp","volume":"13","author":"Ripa","year":"1987","journal-title":"Drugs Exp Clin Res"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib152","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/BF02133974","article-title":"Toxic megacolon complicating pseudomembranous enterocolitis","volume":"38","author":"Trudel","year":"1995","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib153","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00384-003-0541-9","article-title":"Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis","volume":"19","author":"Elinav","year":"2004","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib154","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","article-title":"Intravenous immunoglobulin therapy for severe Clostridium difficile colitis","volume":"41","author":"Salcedo","year":"1997","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib155","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jac\/dkh176","article-title":"Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea","volume":"53","author":"Wilcox","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib156","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10350-006-0511-8","article-title":"Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea","volume":"49","author":"McPherson","year":"2006","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib157","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.40.2.373","article-title":"Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins","volume":"40","author":"Kelly","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib158","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/IAI.59.6.2215-2218.1991","article-title":"Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate","volume":"59","author":"Lyerly","year":"1991","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib159","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.40.2.373","article-title":"Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins","volume":"40","author":"Kelly","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/jmm.0.45773-0","article-title":"Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data","volume":"54","author":"van Dissel","year":"2005","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib161","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/gut.44.2.212","article-title":"Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine","volume":"44","author":"Warny","year":"1999","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib162","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/AAC.41.2.236","article-title":"Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract","volume":"41","author":"Kelly","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib163","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001432-200006000-00003","article-title":"Non-antibiotic therapy for Clostridium difficile infection","volume":"13","author":"Banerjee","year":"2000","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.mcna.2006.07.011_bib164","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","article-title":"Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia","volume":"298","author":"Bartlett","year":"1978","journal-title":"N Engl J Med"},{"issue":"Suppl 22","key":"10.1016\/j.mcna.2006.07.011_bib165","first-page":"41","article-title":"Therapeutic trials of antibiotic associated colitis","author":"Mogg","year":"1980","journal-title":"Scand J Infect Dis Suppl"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib166","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/bjs.1800690306","article-title":"Randomized controlled trial of colestipol in antibiotic-associated colitis","volume":"69","author":"Mogg","year":"1982","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib167","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/141.1.92","article-title":"Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins","volume":"141","author":"Taylor","year":"1980","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib168","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/adc.88.4.342","article-title":"Corticosteroid treatment of severe, non-responsive Clostridium difficile induced colitis","volume":"88","author":"Cavagnaro","year":"2003","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib169","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1542-3565(04)00677-9","article-title":"Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized controlled study","volume":"3","author":"Lewis","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2036.2005.02304.x","article-title":"Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea","volume":"21","author":"Lewis","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib171","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/169.6.1291","article-title":"Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis","volume":"169","author":"Heerze","year":"1994","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib172","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/AAC.45.8.2340-2347.2001","article-title":"GT160\u2013246, a toxin binding polymer for treatment of Clostridium difficile colitis","volume":"45","author":"Kurtz","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib173","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1529\/biophysj.104.041277","article-title":"Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea","volume":"87","author":"Braunlin","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.mcna.2006.07.011_bib174","unstructured":"Davidson D, Peppe J, Louie T. A phase 2 study of the toxin binding polymer tolevamer in patients with Clostridium difficile associated diarrhea. First International Clostridium difficile Symposium. Kranjska Gora, Slovenia, May 5\u20138, 2004."},{"key":"10.1016\/j.mcna.2006.07.011_bib175","unstructured":"Davidson D, Peppe J, Louie T, et\u00a0al. Aphase 2 study of the toxin binding polymer tolevamer in patients with Clostridium difficile associated diarrhea (Abstract P-548). Program and abstracts of the 14th European Congress of Clinical Microbiology and Infectious Diseases. Prague, Czech Republic, 2004."},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib176","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/506349","article-title":"Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea","volume":"43","author":"Louie","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib177","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1463-1318.2005.00876.x","article-title":"The outcome of surgery in fulminant Clostridium difficile colitis","volume":"8","author":"Koss","year":"2006","journal-title":"Colorectal Dis"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib178","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s10350-004-0672-2","article-title":"Outcome after colectomy for Clostridium difficile colitis","volume":"47","author":"Longo","year":"2004","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib179","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1440-1622.2001.02083.x","article-title":"Fatal Clostridium difficile infection of the small bowel after complex colorectal surgery","volume":"71","author":"Tjandra","year":"2001","journal-title":"ANZ J Surg"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0750-7658(02)00806-7","article-title":"Clostridium difficile small intestinal involvement occurring after total colectomy","volume":"21","author":"Duracher","year":"2002","journal-title":"Ann Fr Anesth Reanim"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib181","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/322675","article-title":"Clostridium difficile small bowel enteritis occurring after total colectomy","volume":"33","author":"Freiler","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib182","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF02237205","article-title":"Pseudomembranous enteritis after proctocolectomy: report of a case","volume":"43","author":"Vesoulis","year":"2000","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib183","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.161.4.525","article-title":"Clostridium difficile\u2013associated diarrhea: a review","volume":"161","author":"Mylonakis","year":"2001","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib184","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/jhin.2001.0943","article-title":"Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea","volume":"48","author":"Alonso","year":"2001","journal-title":"J Hosp Infect"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0195-6701(98)90062-7","article-title":"Recurrence of symptoms in Clostridium difficile infection\u2014relapse or reinfection?","volume":"38","author":"Wilcox","year":"1998","journal-title":"J Hosp Infect"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2006.07.011_bib186","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1093\/clinids\/6.Supplement_1.S235","article-title":"Treatment of antibiotic-associated pseudomembranous colitis","volume":"6","author":"Bartlett","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib187","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1572-0241.1998.00541.x","article-title":"Clostridium difficile colitis: factors influencing treatment failure and relapse\u2014a prospective evaluation","volume":"93","author":"Nair","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib188","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9343(81)90369-7","article-title":"Treatment of Clostridium difficile colitis and diarrhea with vancomycin","volume":"71","author":"Silva","year":"1981","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib189","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12019-004-0013-3","article-title":"Recurrent Clostridium difficile colitis","volume":"30","author":"Joyce","year":"2004","journal-title":"Compr Ther"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"Aas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib191","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3810\/pgm.2002.11.1345","article-title":"Recurrent Clostridium difficile colitis. Tackling a tenacious nosocomial infection","volume":"112","author":"Joyce","year":"2002","journal-title":"Postgrad Med"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib192","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/gut.49.1.152","article-title":"Recurrent Clostridium difficile diarrhoea","volume":"49","author":"Kyne","year":"2001","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib193","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib194","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00004836-200405000-00005","article-title":"Factors associated with failure of metronidazole in Clostridium difficile-associated disease","volume":"38","author":"Fernandez","year":"2004","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/502603","article-title":"Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study","volume":"26","author":"Modena","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.mcna.2006.07.011_bib196","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/JCM.42.8.3635-3643.2004","article-title":"Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county","volume":"42","author":"Noren","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib197","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/159.2.340","article-title":"Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism","volume":"159","author":"Johnson","year":"1989","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2006.07.011_bib198","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/JCM.41.7.3413-3414.2003","article-title":"Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea","volume":"41","author":"Tang-Feldman","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib199","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1099\/jmm.0.45808-0","article-title":"An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile","volume":"54","author":"Alonso","year":"2005","journal-title":"J Med Microbiol"},{"issue":"24","key":"10.1016\/j.mcna.2006.07.011_bib200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.271.24.1913","article-title":"A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease","volume":"271","author":"McFarland","year":"1994","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib201","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/501553","article-title":"Recurrent Clostridium difficile disease: epidemiology and clinical characteristics","volume":"20","author":"McFarland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Pt 2","key":"10.1016\/j.mcna.2006.07.011_bib202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/jmm.0.45753-0","article-title":"Alternative treatments for Clostridium difficile disease: what really works?","volume":"54","author":"McFarland","year":"2005","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib203","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mcna.2006.07.011_bib204","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/318130","article-title":"The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii","volume":"31","author":"Surawicz","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib205","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8574","key":"10.1016\/j.mcna.2006.07.011_bib206","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(87)92646-8","article-title":"Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG","volume":"2","author":"Gorbach","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib207","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00005176-199508000-00016","article-title":"Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG","volume":"21","author":"Biller","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1 Suppl","key":"10.1016\/j.mcna.2006.07.011_bib208","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0002-9270(99)00809-6","article-title":"The effect of probiotics on Clostridium difficile diarrhea","volume":"95","author":"Pochapin","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"6\u20137","key":"10.1016\/j.mcna.2006.07.011_bib209","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00365540310010985","article-title":"Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial","volume":"35","author":"Wullt","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00365548409087145","article-title":"Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces","volume":"16","author":"Schwan","year":"1984","journal-title":"Scand J Infect Dis"},{"issue":"8648","key":"10.1016\/j.mcna.2006.07.011_bib211","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0140-6736(89)92749-9","article-title":"Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients","volume":"1","author":"Tvede","year":"1989","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib212","first-page":"3283","article-title":"Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope","volume":"95","author":"Persky","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib213","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.mcg.0000128988.13808.dc","article-title":"Bacteriotherapy using fecal flora: toying with human motions","volume":"38","author":"Borody","year":"2004","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib214","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","article-title":"Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity","volume":"171","author":"Pepin","year":"2004","journal-title":"CMAJ"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib215","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1503\/cmaj.1041694","article-title":"C. difficile: by the numbers","volume":"171","author":"Eggertson","year":"2004","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.mcna.2006.07.011_bib216","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1503\/cmaj.1041435","article-title":"Quebec to report on Clostridium difficile in 2005","volume":"171","author":"Pindera","year":"2004","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.mcna.2006.07.011_bib217","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1503\/cmaj.1041250","article-title":"C. difficile hits Sherbrooke, Que., hospital: 100 deaths","volume":"171","author":"Eggertson","year":"2004","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.mcna.2006.07.011_bib218","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1503\/cmaj.1041033","article-title":"Quebec strikes committee on Clostridium difficile","volume":"171","author":"Eggertson","year":"2004","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.mcna.2006.07.011_bib219","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1503\/cmaj.1040979","article-title":"Hospitals battling outbreaks of C. difficile","volume":"171","author":"Eggertson","year":"2004","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.mcna.2006.07.011_bib220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/501126","article-title":"Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada","volume":"42","author":"Pepin","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2006.07.011_bib221","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","article-title":"Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole","volume":"40","author":"Musher","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2006.07.011_bib222","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","article-title":"Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea","volume":"128","author":"Sougioultzis","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2006.07.011_bib223","unstructured":"McDonald LC, Killgore GE, Thompson A, et\u00a0al. Emergence of an epidemic strain of Clostridium difficile in the United States, 2001\u20134: potential role for virulence factors and antimicobial resistance strains (abstract LB-2). 42nd Annual Meeting of the Infectious Disease Society of America, Boston. Alexandria (VA): Infectious Disease Society of America; 2004. p. 58."},{"key":"10.1016\/j.mcna.2006.07.011_bib224","unstructured":"Warny M, Pepin J, Fang A, et\u00a0al. Increased toxins A and B production in an emerging strain of Clostridium difficile. 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. Los Angeles, April 9\u201312, 2005."},{"issue":"10","key":"10.1016\/j.mcna.2006.07.011_bib225","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1503\/cmaj.050470","article-title":"C. difficile strain 20 times more virulent","volume":"172","author":"Eggertson","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.mcna.2006.07.011_bib226","series-title":"British authorities probe hospital superbug","author":"Ross","year":"2005"},{"key":"10.1016\/j.mcna.2006.07.011_bib227","unstructured":"Barbut F, Mastrantonio P, Delm\u00e9e M, et\u00a0al. European prospective study of Clostridium difficile strrains: phenotypic and genotypic characterization of the isolates from different clinical status: interim results. Program and abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases. Nice (France), April 1\u20134, 2006."}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T13:01:03Z","timestamp":1628341263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712506000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":227,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0025712506000915"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2006.07.011","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}